Comparing Cefixime, Cefpodoxime and Ofloxacin as Anti-Microbial Agents and their Effects on Gut Microbiota

Authors

  • Kartik Singh  Guru Gobind Singh Indraprastha University, Delhi, India
  • Manju Mohan  University of Madras, Chennai, Tamil Nadu, India
  • Shrishti Nautiyal  Amity University, Noida, Uttar Pradesh, India

DOI:

https://doi.org//10.32628/IJSRST207619

Keywords:

Cefpodoxime, Ofloxacin, Cefixime, Gut Flora, Biological Systems, Biological Systems

Abstract

The present review is based mainly on papers published between 190 and 2020 and gives information about the effects of Cefpodoxime, Ofloxacin and Cefixime on the gut flora, biological systems and its possible role in antibiotics. The main aim of this report is to highlight their role as an antibiotic and its relationship to the gut microbiota.

References

  1. Edlund, C. et al. Comparative Effects of Moxifloxacin and Clarithromycin on the Normal Intestinal Microflora. Scand J Infect Dis vol. 32 (2000).
  2. Edlund’, C., Sjostedt2, S., Nord’, C. E. & Nord, C. E. Comparative Effects of Levofloxacin and Ofloxacin on the Normal Oral and Intestinal M i crof I o ra. Scand J Infect Dis vol. 29 (1997).
  3. Iizumi, T. et al. Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice. Gut Pathog. 8, 1–10 (2016).
  4. Hooton, T. M., Roberts, P. L. & Stapleton, A. E. Cefpodoxime vs Ciprofloxacin for Short-Course Treatment of Acute Uncomplicated Cystitis A Randomized Trial. 5JAC445647.
  5. Pecquet, S., Andremont, A. & Tancrede, C. Effect of oral ofloxacin on fecal bacteria in human volunteers. Antimicrob. Agents Chemother. 31, 124–125 (1987).
  6. Hayakawa, I., Atarashi, S. & Yokohama, S. Synthesis and Antibacterial Activities of Optically Active Ofloxacin. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (1986).
  7. Hardy, D., Amsterdam, D., Mandell, L. A. & Rotstein, C. and Other Antimicrobial Agents against Bloodstream Isolates of Gram-Positive Cocci. vol. 44 (2000).
  8. Brook, I. & David Ledney, G. Effect of antimicrobial therapy on the gastrointestinal bacterial flora, infection and mortality in mice exposed to different doses of irradiation. Journal of Antimicrobial Chemotherapy vol. 33 (1994).
  9. Lang, R., Lbhner, M., Segev, S. & Rubinstein, E. Ofloxacin and the gastrointestinal tract: a potential role in the treatment of bacterial enteritis. Journal of Antimicrobial Chemotherapy vol. 26 (1990).
  10. Chachaty, E. et al. Presence of Clostridium di;icile and Antibiotic and ,B-Lactamase Activities in Feces of Volunteers Treated with Oral Cefixime, Oral Cefpodoxime Proxetil, or Placebo. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY vol. 36 (1992).
  11. Brismar, B., Edlund, C. & Nord, C. E. Impact of Cefpodoxime Proxetil and Amoxiciilin on the Normal Oral and Intestinal Microflora. New Antimicrobial Agent vol. 12.13603 (2).
  12. Hughes, G. S. et al. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil The effects of alteration of gastric pH and food on the pharmacokinetics of 200 mg doses of cefpodoxime.
  13. Ghosh, A. & Chatterjee, S. Comparison of efficacy and safety of cefpodoxime and amoxicillin-clavulanate potassium in paediatric acute otitis media in children below two years: A prospective longitudinal study. J. Clin. Diagnostic Res. 11, FC01–FC04 (2017).
  14. Wiedemann, B. & Jansen, A. Antibacterial activity of cefpodoxime proxetil in a pharmacokinetic in-vitro model. Journal of Antimicrobial Chemotherapy vol. 26 (1990).
  15. Cox, C. E., Graveline, J. F. & Luongo, J. M. Review of Clinical Experience in the United States with Cefpodoxime Proxetil in Adults with Uncomplicated Urinary Tract Infections. Drugs vol. 42 (1991).
  16. Cefpodoxime: Comparative Antibacterial Activity, Influence of Growth Conditions, and Bactericidal Activity.
  17. Stentz, R. et al. Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against β-lactam antibiotics. J. Antimicrob. Chemother. 70, 701–709 (2015).
  18. Chugh, K. & Agrawal, S. Cefpodoxime?: Pharmacokinetics and Therapeutic Uses.
  19. Khan, F. A., Zahoor, M., Islam, N. U. & Hameed, R. Synthesis of Cefixime and Azithromycin Nanoparticles: An Attempt to Enhance Their Antimicrobial Activity and Dissolution Rate. J. Nanomater. 2016, (2016).
  20. Pinatih, K. J. P., Suastika, K., Sukrama, I. D. M. & Sujaya, I. N. Increase in bacteroides/firmicutes ratio after early-life repeated administration of Cefixime in Rat. Bali Med. J. 6, (2017).
  21. Chaudhary, M. et al. Antihypertensive medication prescribing patterns in crimson hospital View project EFFICACY OF CEFIXIME IN THE TREATMENT OF URINARY TRACT INFECTION. www.wjpps.com vol. 4 (2015).
  22. Matsumoto, Y. et al. Mechanism of therapeutic effectiveness of cefixime against typhoid fever. Antimicrob. Agents Chemother. 45, 2450–2454 (2001).
  23. Krishnan, P., Stalin, M. & Balasubramanian, S. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai. Indian J. Pathol. Microbiol. 52, 505–508 (2009).
  24. Arshad, H. M., Mohiuddin, O. A. & Azmi, M. B. Comparative in vitro antibacterial analysis of different brands of cefixime against clinical isolates of Staphylococcus aureus and Escherichia coli. J. Appl. Pharm. Sci. 2012, 109–113.
  25. Ludwig, E. & Ludwig, E. Cefixime in the Treatment of Respiratory and Urinary Tract Infections. Chemotherapy vol. 44 (1998).
  26. Knapp, C. C., Sierra-Madero, J. & Washington, J. A. Antibacterial Activities of Cefpodoxime, Cefixime, and Ceftriaxone. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY vol. 32 (1988).
  27. Counts, G. W., Baugher, L. K., Ulness, B. K. & Hamilton, D. J. New Antimicrobial Agents Comparative in Vitro Activity of the New Oral Cephalosporin Cefixime. J. Clin. Microbiol. Infect. Dis.
  28. Moazzezy, N., Karam, M. R. A., Rafati, S., Bouzari, S. & Oloomi, M. Inhibition and eradication activity of truncated α-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilm. PLoS One 15, (2020).
  29. Kwatra, B. A Review on Potential Properties and Therapeutic Applications of DHA and EPA. ijppr.humanjournals 16, 140–176 (2019).
  30. Kwatra, B. Tinospora Crispa As A Future Cure For Obesity/Cholesterol. Int. J. Sci. Technol. Res. 6, 340–341 (2017).
  31. Kwatra, B. A REVIEW ON POTENTIAL PROPERTIES AND THERAPEUTIC APPLICATIONS OF BROMELAIN. www.wjpps.com 8, 488–500 (2019).
  32. Kwatra, B. Holothuroidea (Sea Cucumber): Key to Anti-Aging. Int. J. Sci. Res. 8, 884–884 (2019).
  33. Kwatra, B. & Mudgil, M. PROTONATED CRAB SHELL WASTE AS FUNGAL INHIBITOR. Int. J. Med. Biomed. Stud. 3, 111–116 (2019).
  34. Kwatra, B. A REVIEW ON POTENTIAL PROPERTIES AND THERAPEUTIC APPLICATIONS OF GRAPE SEED EXTRACT. World J. Pharm. Res. 9, 2519–2540 (2020).
  35. Kwatra, B. A REVIEW ON POTENTIAL PROPERTIES AND THERAPEUTIC APPLICATIONS OF BRANCHED CHAIN AMINO. WORLD J. Pharm. Pharm. Sci. 9, 561–588 (2020).
  36. Kwatra, B. COLLAGEN SUPPLEMENTATION?: THERAPY FOR SKIN DISORDERS?: A REVIEW. World J. Pharm. Res. 9, 2504–2518 (2020).
  37. Kwatra, B. A REVIEW ON POTENTIAL PROPERTIES AND THERAPEUTIC APPLICATIONS OF LYCOPENE. Int. J. Med. Biomed. Stud. 4, 33–44 (2020).
  38. Kwatra, B. & Mudgil, M. LIGHT ASSISTED TIO2-BASED NANOCOMPOSITE SYSTEMS: A NOVEL TREATMENT FOR CANCER. Int. J. Med. Biomed. Stud. 4, 28–32 (2020).
  39. Kwatra, B. A Review on Potential Properties and Therapeutic Applications of Vitamin D. Int. J. Sci. Res. 9, 682–691 (2020).
  40. Kwatra, B. HYDROQUINONE: A novel growth inhibitor and apoptosis inducer in U-251 MG CELLS. Int. J. Med. Biomed. Stud. 3, 15–16 (2019).
  41. Bharat Kwatra. Procuring Natural Dye for Solar Cell Using Leaf Waste. Int. J. Sci. Eng. Res. 7, 46–47 (2019).
  42. Kwatra, B. HACKING THE BLOOD-BRAIN BARRIER. Eur. J. Biol. Med. Sci. Res. 5, 10–13 (2017).
  43. Kwatra, B. EXPRESSION AND CHARACTERIZATION IN PICHIA PASTORIS BY CLONING OF DELTA 4 DESATURASE FROM ISOCHRYSIS GALBANA. Indian J. Appl. Res. 9, 1–2 (2019).
  44. Kwatra, B. CALCIUM AND IRON ABSORPTION: INVITRO STUDIES. Int. J. Med. Biomed. Stud. 3, 59–61 (2019).
  45. Kwatra, B. Allicin-An After Digestion Antimicrobial Agent. ACTA Sci. Microbiol. 2, 48–51 (2019).
  46. Kwatra, B. LOCATOR THEORY FOR ELE-MENTS IN PERIODIC TABLE ‘LEPT’. Glob. J. Pure Appl. Chem. Res. 5, 9–10 (2017).
  47. Kwatra, B. & A, A. UTERINE CANCER: SEX DOMINANT CHARACTER. Int. J. Adv. Res. 08, 663–667 (2020).
  48. Kwatra, B. Studies on People Employed in High Risk Workplace?: Between Genetic Polymorphism for Tumor Necrosis Factor ( TNF- Α ) and Blood Pressure. Int. J. Innov. Res. Technol. 6, 268–270 (2020).
  49. Kwatra, B. & Arora, C. Investigation of Conductance Quantization with Magnetic Field Control and Application of Biosensor. Int. J. Innov. Res. Technol. 6, 271–272 (2020).
  50. Kwatra, B. Candidate genes of OCD interacts with human retrovirus to form new link in inflammatory hypothesis. Int. J. Sci. Appl. Res. 7, 1–2 (2020).
  51. Kwatra, B. COLLAGEN SUPPLEMENTATION?: THERAPY FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS AND OSTEOARTHRITIS?: A REVIEW. WORLD J. Pharm. Pharm. Sci. 9, 589–604 (2020).
  52. Kwatra, B. THE SIMVASTATIN AND DMXAA ON THE CO-CULTURE OF B16.F10 MELANOMA CELLS AND MACROPHAGES SHOWS ANTITUMOR ACTIVITY. World J. Pharm. Res. 8, 1318–1319 (2019).
  53. Kwatra, B. Bioactive-Compounds: alternative to control Candida spp. Int. J. Sci. Res. Rev. 8, 221–223 (2019).
  54. Kwatra, B. Effects of Mineral Separation by Time and Enteric Coating Mechanism for Calcium and Iron Absorption in Mammalia. Int. J. Sci. Res. 8, 1265–1270 (2019).
  55. Kwatra, B. Maprovit 3, 6, 9: Perfect Companion of your Immune System to Fight Corona Virus Hit. Int. J. Sci. Res. 9, 241–241 (2020).
  56. Kwatra, B. & Mudgil, M. Untangling the Mathematical Relation Between Natural Selection and Adaptive Radiation Using Macromolecules and Microevolutionary Forces. Int. J. Sci. Res. Sci. Technol. IJSRST | 7, 313–339 (2020).
  57. Kwatra, B. MECHANISMS OF PATTERN FORMATION OF FBP17 IN MAST CELLS. Int. J. Adv. Res. 7, 413–414 (2019).
  58. Mudgil1, M. & Kwatra2, B. Mosquito Menace Aim: Observing the life cycle of Aedes aegypti mosquito and understanding its behavior towards different natural oils for encouraging natural methods of repellence. Int. J. Sci. Res. 8, 1314–1315 (2019). 1,2,11–20,3,21–30,4–1031–60

International Journal of Scientific Research in Science and Technology

Downloads

Published

2020-12-30

Issue

Volume 7, Issue 6, November-December-2020

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Kartik Singh, Manju Mohan, Shrishti Nautiyal, " Comparing Cefixime, Cefpodoxime and Ofloxacin as Anti-Microbial Agents and their Effects on Gut Microbiota, International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 7, Issue 6, pp.131-152, November-December-2020. Available at doi : https://doi.org/10.32628/IJSRST207619